The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea

Park, Hyeree; Seo, Sang Uk; Park, Jong Heon; Yoo, Seong Ho; Keam, Bhumsuk; Shin, Aesun

doi:10.4178/epih.e2022053

Cited by 19 publications

(10 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This was when the aggregation of confirmed cases was low, with a daily average of 39.3 cases, and social distancing was converted to the degree of daily life 2 . A previous study reported that when comparing the monthly cancer screening rates in 2019 and 2020, the figure increased in June compared to March 2020 26 . Unlike cancer screening, it is extremely difficult to delay ED visits or endure sickness without urgent action due to the characteristics of CVD itself, well known as being time-sensitive.…”

Section: Discussionmentioning

confidence: 95%

Emergency department visits of newly diagnosed cardiovascular disease patients in Korea during the COVID-19 pandemic

Baek,

Seo,

Cho

et al. 2024

Sci Rep

Self Cite

View full text Add to dashboard Cite

This study aimed to examine the impact of the COVID-19 pandemic on the emergency department (ED) visits of cardiovascular disease (CVD) patients. The customized data of the National Health Insurance Service (NHIS) from 2017 to 2020 were analyzed. CVD patients were defined by the code ‘V192’ based on the NHIS coverage benefit expansion policy. The number of ED visits of CVD patients, as well as executed procedures in 2020 (during the pandemic), were compared to the corresponding average numbers in 2018 and 2019 (prepandemic). Stratification by age group, residential area and hospital location was performed. The number of ED visits of newly diagnosed CVD patients decreased by 2.1% nationwide in 2020 (2018–2019: 97,041; 2020: 95,038) and decreased the most (by 14.1%) in March (2018–2019: 8539; 2020: 7334). However, the number of executed procedures increased by 1.1% nationwide in 2020 (2018–2019: 74,696; 2020: 75,520), while it decreased by 11.9% in April (2018–2019: 6603; 2020: 5819). The most notable decreases in the number of newly diagnosed CVD patients (31.7%) and procedures (29.2%) in March 2020 were observed in the Daegu·Gyeongbuk area. CVD patients living in the epicenter of the COVID-19 pandemic may experience difficulty accessing healthcare facilities and receiving proper treatment.

show abstract

Section: Discussionmentioning

confidence: 95%

Emergency department visits of newly diagnosed cardiovascular disease patients in Korea during the COVID-19 pandemic

Baek,

Seo,

Cho

et al. 2024

Sci Rep

Self Cite

View full text Add to dashboard Cite

show abstract

“…Indeed, especially during the period of high-intensity social distancing, there was a significant decrease in the incidence of stomach, colorectal, liver cancer, and breast cancer. Considering that stomach, liver, colorectal, breast, cervical, and lung cancers, can be screened through the Korean National Cancer Screening Program [ 40 ], it can be attributed largely to the significant decrease in cancer screening rates during the COVID-19 pandemic [ 5 , 41 ].…”

Section: Discussionmentioning

confidence: 99%

Impact of coronavirus disease 2019 on cancer care: How the pandemic has changed cancer utilization and expenditures

Sim,

Shin,

Lee

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Purpose Since identified in December 2019, the novel coronavirus disease 2019 (COVID-19) has had a global impact on medical resource use and costs for patients with cancer in South Korea. This study aimed to identify the medical use and costs among patients with cancer during the COVID-19 pandemic, to predict these patterns in South Korea in the future. Methods We conducted a secondary claims data analysis using the National Health Insurance Service database for the calendar period of 2019–2020. Monthly relative percent changes in cancer incidence, medical use, and billing costs for medical care utilization by cancer type were calculated. Then, the medical use and costs after January 2020 were predicted using a time series model with data before the COVID-19 outbreak (2014–2019). Results The incidence of cancer diagnoses has seen a notable decline since the outbreak of the COVID-19 in 2020 as compared to 2019. Despite the impact of COVID-19, there hasn’t been a distinct decline in outpatient utilization when compared to inpatient utilization. While medical expenses for both inpatient and outpatient visits have slightly increased, the number of patients treated for cancer has decreased significantly compared to the previous year. In June 2020, overall outpatient costs experienced the highest increase (21.1%), while individual costs showed the most significant decrease (-4.9%) in June 2020. Finally, the number of hospitalisations and outpatient visits increased slightly from June–July in 2020, reducing the difference between the actual and predicted values. The decrease in the number of inpatient hospitalisations (-22~-6%) in 2020 was also high. Conclusions The overall use of medical services by patients with cancer decreased in 2020 compared with that in the pre-COVID-19 pandemic period. In the future, the government should consider how to recover from the COVID-19 pandemic, and establish permanent health policies for patients with cancer.

show abstract

“…Notably, the screening rate can also be influenced by external factors, such as the COVID-19 pandemic ( 32 , 33 ). In 2021, when COVID-19 was serious and several social distancing policies had been implemented, the opportunistic screening rate had increased to 18% from approximately 10% in previous years.…”

Section: Discussionmentioning

confidence: 99%

Socioeconomic inequality in organized and opportunistic screening for gastric cancer: results from the Korean National Cancer Screening Survey 2009–2022

Luu,

Lee,

Jun

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

ObjectivesThis study aimed to evaluate the socioeconomic inequality in gastric cancer (GC) screening in Korea. Socioeconomic inequality was assessed using both organized and opportunistic screening according to income and educational level.MethodsGC screening data were obtained from the 2009–2022 Korean National Cancer Screening Survey. The final analysis included 47,163 cancer-free men and women. The weighted cancer screening rate was estimated using joinpoint regression. The inequality indices were measured in terms of both the absolute slope index of inequality (SII) and the relative index of inequality (RII) using the Poisson regression model.ResultsThe organized screening rate for GC increased from 38.2% in 2009 to 70.8% in 2022, whereas the opportunistic screening rate decreased from 18.8 to 4.5%. Regarding educational inequality, a negative SII value was observed [−3.5, 95% confidence interval (CI), −7.63–0.83%] in organized screening, while a positive SII (9.30%; 95% CI, 6.69–11.91%) and RII (1.98%; 95% CI, 1.59–2.46) were observed in opportunistic screening. Furthermore, income inequality was not found in organized GC screening; however, overall SII and RII for opportunistic screening were 7.72% (95% CI, 5.39–10.5) and 1.61 (95% CI, 1.42–1.81), respectively.ConclusionOrganized screening rates have grown gradually over time and account for the majority of GC screenings in South Korea. While no socioeconomic inequalities were found in organized screening, significant socioeconomic inequalities were found in opportunistic screening.

show abstract

The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea

Cited by 19 publications

References 40 publications

Emergency department visits of newly diagnosed cardiovascular disease patients in Korea during the COVID-19 pandemic

Emergency department visits of newly diagnosed cardiovascular disease patients in Korea during the COVID-19 pandemic

Impact of coronavirus disease 2019 on cancer care: How the pandemic has changed cancer utilization and expenditures

Socioeconomic inequality in organized and opportunistic screening for gastric cancer: results from the Korean National Cancer Screening Survey 2009–2022

Contact Info

Product

Resources

About